Skip to main content
Log in

High cost of childhood asthma in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Funded by Novartis Pharmaceuticals Inc.

Reference

  • Sullivan PW, et al. The national cost of asthma among school-aged children in the United States. Annals of Allergy, Asthma and Immunology 119: 246-252.e1, No. 3, Sep 2017

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High cost of childhood asthma in the US. PharmacoEcon Outcomes News 787, 18 (2017). https://doi.org/10.1007/s40274-017-4346-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4346-4

Navigation